Literature DB >> 17379635

Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy.

Shengwen Zhang1, Jamie M Zeitzer, Takeshi Sakurai, Seiji Nishino, Emmanuel Mignot.   

Abstract

Recent population studies have identified important interrelationships between sleep duration and body weight regulation. The hypothalamic hypocretin/orexin neuropeptide system is able to influence each of these. Disruption of the hypocretin system, such as occurs in narcolepsy, leads to a disruption of sleep and is often associated with increased body mass index. We examined the potential interrelationship between the hypocretin system, metabolism and sleep by measuring locomotion, feeding, drinking, body temperature, sleep/wake and energy metabolism in a mouse model of narcolepsy (ataxin-ablation of hypocretin-expressing neurons). We found that locomotion, feeding, drinking and energy expenditure were significantly reduced in the narcoleptic mice. These mice also exhibited severe sleep/wake fragmentation. Upon awakening, transgenic and control mice displayed a similar rate of increase in locomotion and food/water intake with time. A lack of long wake episodes partially or entirely explains observed differences in overall locomotion, feeding and drinking in these transgenic mice. Like other parameters, energy expenditure also rose and fell depending on the sleep/wake status. Unlike other parameters, however, energy expenditure in control mice increased upon awakening at a greater rate than in the narcoleptic mice. We conclude that the profound sleep/wake fragmentation is a leading cause of the reduced locomotion, feeding, drinking and energy expenditure in the narcoleptic mice under unperturbed conditions. We also identify an intrinsic role of the hypocretin system in energy expenditure that may not be dependent on sleep/wake regulation, locomotion, or food intake. This investigation illustrates the need for coordinated study of multiple phenotypes in mouse models with altered sleep/wake patterns.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379635      PMCID: PMC2075199          DOI: 10.1113/jphysiol.2007.129510

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  55 in total

1.  Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.

Authors:  R A España; B A Baldo; A E Kelley; C W Berridge
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Energy expenditure by intracerebroventricular administration of orexin to anesthetized rats.

Authors:  J Wang; T Osaka; S Inoue
Journal:  Neurosci Lett       Date:  2001-11-23       Impact factor: 3.046

3.  Inhibition of prostaglandin synthesis reduces hyperthermic reactions induced by hypocretin-1/orexin A.

Authors:  M Monda; A Viggiano; P Mondola; V De Luca
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

4.  Increased prevalence of obesity in narcoleptic patients and relatives.

Authors:  N Dahmen; J Bierbrauer; M Kasten
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

5.  Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.

Authors:  Y Yoshida; N Fujiki; T Nakajima; B Ripley; H Matsumura; H Yoneda; E Mignot; S Nishino
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

6.  Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; S Nevsimalova; G J Lammers; J Vankova; M Okun; W Rogers; S Brooks; E Mignot
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

7.  Differential expression of orexin receptors 1 and 2 in the rat brain.

Authors:  J N Marcus; C J Aschkenasi; C E Lee; R M Chemelli; C B Saper; M Yanagisawa; J K Elmquist
Journal:  J Comp Neurol       Date:  2001-06-18       Impact factor: 3.215

8.  Orexin (hypocretin) neurons contain dynorphin.

Authors:  T C Chou; C E Lee; J Lu; J K Elmquist; J Hara; J T Willie; C T Beuckmann; R M Chemelli; T Sakurai; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

9.  Feeding and activity induced by orexin A in the lateral hypothalamus in rats.

Authors:  Catherine M Kotz; Jennifer A Teske; James A Levine; ChuanFeng Wang
Journal:  Regul Pept       Date:  2002-03-15

10.  Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.

Authors:  Carsten T Beuckmann; Christopher M Sinton; S Clay Williams; James A Richardson; Robert E Hammer; Takeshi Sakurai; Masashi Yanagisawa
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

View more
  46 in total

Review 1.  Sleep and obesity: a focus on animal models.

Authors:  Vijayakumar Mavanji; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Neurosci Biobehav Rev       Date:  2012-01-16       Impact factor: 8.989

2.  Effects of sleep on the cardiovascular and thermoregulatory systems: a possible role for hypocretins.

Authors:  H Schwimmer; H M Stauss; F Abboud; S Nishino; E Mignot; J M Zeitzer
Journal:  J Appl Physiol (1985)       Date:  2010-08-12

Review 3.  Orexin receptors: pharmacology and therapeutic opportunities.

Authors:  Thomas E Scammell; Christopher J Winrow
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

4.  Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice.

Authors:  Stefano Bastianini; Alessandro Silvani; Chiara Berteotti; Jean-Luc Elghozi; Carlo Franzini; Pierluigi Lenzi; Viviana Lo Martire; Giovanna Zoccoli
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

5.  The spectrum of neurobehavioral sequelae after repetitive mild traumatic brain injury: a novel mouse model of chronic traumatic encephalopathy.

Authors:  Anthony L Petraglia; Benjamin A Plog; Samantha Dayawansa; Michael Chen; Matthew L Dashnaw; Katarzyna Czerniecka; Corey T Walker; Tyler Viterise; Ollivier Hyrien; Jeffrey J Iliff; Rashid Deane; Maiken Nedergaard; Jason H Huang
Journal:  J Neurotrauma       Date:  2014-06-12       Impact factor: 5.269

6.  Loss of polyubiquitin gene Ubb leads to metabolic and sleep abnormalities in mice.

Authors:  K-Y Ryu; N Fujiki; M Kazantzis; J C Garza; D M Bouley; A Stahl; X-Y Lu; S Nishino; R R Kopito
Journal:  Neuropathol Appl Neurobiol       Date:  2009-12-08       Impact factor: 8.090

Review 7.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

8.  A major role for perifornical orexin neurons in the control of glucose metabolism in rats.

Authors:  Chun-Xia Yi; Mireille J Serlie; Mariette T Ackermans; Ewout Foppen; Ruud M Buijs; Hans P Sauerwein; Eric Fliers; Andries Kalsbeek
Journal:  Diabetes       Date:  2009-07-10       Impact factor: 9.461

9.  Why we sleep: the temporal organization of recovery.

Authors:  Emmanuel Mignot
Journal:  PLoS Biol       Date:  2008-04-29       Impact factor: 8.029

10.  Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.

Authors:  Satvinder Kaur; Stephen Thankachan; Suraiya Begum; Meng Liu; Carlos Blanco-Centurion; Priyattam J Shiromani
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.